Northeast ALS Consortium--Publications

Publications

Increased incidence of deep venous thrombosis in ALS

Neurology 2007; Vol. 68: 76-77.

MM Qureshi, ME Cudkowicz, H Zhang, E Raynor

Trial of Celecoxib in Amyotrophic Lateral Sclerosis

Annals of Neurology, July 2006, Vol. 60, No. 1, 22-31.

Merit. E. Cudkowicz, MD, MSc, Jeremy. M. Shefner, MD, PhD, David. A. Schoenfeld, PhD, Hui. Zhang, Katrin. I. Andreasson, MD, Jeffrey D. Rothstein, MD PhD, Daniel. B. Drachman, MD and the Northeast ALS Consortium.

Revised Statistical MUNE in the Celecoxib/ALS Trial

Muscle and Nerve, Feb. 2006, 35(2): 228-34.

J.M.Shefner, M.E.Cudkowicz, H.Zhang, D.Schoenfeld, D.Jillapilli, and the Northeast NEALS Consortium

Tolerance of high-dose (3,000) mg/day) coenzyme Q10 in ALS

K.L.Ferrante, BA, J.Shefner, MD, PhD, H.Zhang, MS, R.Betensky, PhD, M.O'Brien, MPH, PT, H.Yu, MS, M.Fantasia, MPH, J.Taft, MPAS, PA, M.F.Beal, MD, B.Traynor, MD, K.Newhall, BS, P.Donofrio, MD, J.Caress, MD, C.Ashburn, RN, MSN, B.Freiberg, PT, C.O'Neill, BS, C.Paladenech, RRT, T.Walker, RN, BSN, A.Pestronk, MD, B.Abrams, RN, J.Florence, MHS, DPT, R.Renna, RN, J. Schierbecker, MHS, PT, B.Malkus, MHS, PT, and M.Cudkowicz, MD, MSc.

The Use of Statistical MUNE in a Multicenter Clinical Trial

Muscle and Nerve 30: 463-469, 2004.

J.M. Shefner, MD, PhD, M.E.Cudkowicz, MD, H Zhang, MA, D. Schoenfeld, PhD, D. Jillapalli, MD, and the Northeast ALS Consortium.

Functional outcome measures as clinical trial endpoints in Amyotrophic Lateral Sclerosis

Neurology, 2004; 63: 1933-5.

Traynor, B, Zhang, H, Shefner, J, Schoenfeld, D, Cudkowicz, M.

A Clinical Trial of Creatine in ALS

J. M. Shefner, M. E. Cudkowicz, D. Schoenfeld, T. Conrad, J. Taft, M. Chilton, L. Urbinelli, M. Qureshi, H. Zhang, A. Pestronk, J. Caress, E. Sorenson, W. Bradley, C. Lomen-Hoerth, E. Pioro, K. Rezania, M. Ross, R. Pascuzii, T. Heiman-Patterson, R. Tandan, H. Mitsumoto, J. Rothstein, T. Smith-Palmer, D. MacDonald, D. Burke, and the Northeast NEALS Consortium

A Randomized, Placebo-Controlled Trial of Topiramate in Amyotrophic Lateral Sclerosis

Neurology, Aug. 2003; 61: 456 -464.

M. E. Cudkowicz, J. M. Shefner, D. A. Schoenfeld, R. H. Brown, Jr., H. Johnson, M. Qureshi, M. Jacobs, J. D. Rothstein, S. H. Appel, R. M. Pascuzzi, T. D. Heiman-Patterson, P. D. Donofrio, W. S. David, J. A. Russell, R. Tandan, E. P. Pioro, K. J. Felice, J. Rosenfeld, R. N. Mandler, G. M. Sachs, W. G. Bradley, W. M. Raynor, G. D. Baquis, J. M. Belsh, S. Novella, J. Goldstein and J. Hulihan

--top of page--

Abstract (with poster) presented at ANA meeting, Chicago, IL, October 2006

NEALS Arimoclomol Sites: A MultiCenter, Dose Ranging Safety and Pharmacokinetics Study of Arimoclomol in ALS

Annals of Neurology, 2006; 60(S10); S13.

M. Cudkowicz, J. Shefner, E. Simpson, R. H. Brown, Jr., H. Yu, H. Zhang, A. Opoliner, D. Grasso, D. Schoenfeld, S. Wieland, and J. Barber

--top of page--

Abstracts presented at the 17th International Symposium on ALS/MND, Japan, December 2006

Challenges of Data Management in Web-based Multi-site Clinical Trials in Amyotrophic Lateral Sclerosis

Amyotrophic Lateral Sclerosis. 2006. Pages 1 -180; 57 - 58.

A. V. Sherman, M. E. Cudkowicz, H. Yu, S. Balakrishna, A. F. Opoliner

Levetiracetam Treatment for Spasticity in Motor Neuron Diseases

Amotrophic Lateral Sclerosis. 2006. 7:s1, Pages 1 -180; 111 -112.

R. Bedlack, M. Bellanich, M. Bromberg, M. Cudkowicz

A Multicenter, Dose Ranging Safety and Pharmacokinetics Study of Arimoclomol in LS (with poster)

Amotrophic Lateral Sclerosis. 2006. 7:S1, Pages 1 - 180; 113.

M. Cudkowicz, J. Shefner, E. Simpson, D. Grasso, A. Sherman, H. Yu, A. Opoliner, S. Balakrishna. D. Schoenfeld, H. Zhang, D. Finkelstein, J. Taft, M. Watson, A. DiBernardo, D. Pulley, A. Verma, D. Koggan, J. Steele, R. Bedlack, K. Grace, T. Heiman-Patterson, C. Barr, R. Barohn, M. Walsh, L. Heberlin, Z. Simmons, H. Stephens, E. Ensrud, M. Zimmerman, W. David, S. Conn, T. Mozaffar, V. Martin, J. Hung, D. Milan, S. Wieland, J. Barber, and R. Brown

Unified Electronic Data Capture and Data Management System for Clinical Trials and Biomarker Studies in ALS

Amyotrophic Lateral Sclerosis. 2006. 7:S1, Pages 1 - 180; 115 - 116.

A. V. Sherman

Safety and Dose Escalating Study of Oral Sodium Phenylbutyrate in Subjects with ALS (poster)

Cudkowicz ME, Andres PL, Schoenfeld D, Zhang H, Sherman A, Yu H, Opoliner A, Choudry R, Kruczek K, MacDonald S, Matson W, Smith K, Hetherington W, Loya P, Bedlack R, Golightly Y, Maragakis N, Clawson L, Mosier D, Ali N, Kasarskis E, Taylor D, Zivkovic S, Brice V, Sams L, Story M, Ferrante K, Shefner J, Taft J, Brown R, Ferrante, RJ

--top of page--